Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

December 2022 News Roundup

News Opinion CV Team Dispatch

December 2022 News Roundup

December 28, 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

December 22, 2022

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

November 21, 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

TCTMD’s Top 10 Most Popular Stories for June 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

July 04, 2022

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

News Daily News

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Michael O'Riordan

February 16, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.